Table 2. Chest imaging findings, laboratory characteristics, and treatments administered.
| Variables | Total subjects | Deceased | Survivors | P value | |
|---|---|---|---|---|---|
| Chest imaging | < 0.001 | ||||
| None | 147 (41.8) | 0 | 145 (44.8) | ||
| Bilateral infiltration | 165 (46.9) | 22 (91.7) | 142 (43.8) | ||
| Unilateral infiltration | 40 (11.4) | 2 (8.3) | 37 (11.4) | ||
| Laboratory findings | |||||
| Leukocyte, > 10.7 × 109/L | 21 (6.0) | 6 (25.0) | 15 (4.6) | < 0.001 | |
| Lymphocyte, < 1.0 × 109/L | 63 (17.9) | 12 (50.0) | 51 (15.7) | < 0.001 | |
| High aspartate aminotransferase | 89 (25.3) | 14 (58.3) | 74 (22.8) | < 0.001 | |
| High alanine aminotransferase | 56 (15.9) | 3 (12.5) | 52 (16.0) | 0.409 | |
| High lactate dehydrogenase | 63 (17.9) | 12 (50.0) | 51 (15.7) | < 0.001 | |
| High creatinine | 24 (6.8) | 6 (25.0) | 17 (5.2) | < 0.001 | |
| Anemia | 73 (20.7) | 18 (75.0) | 55 (17.0) | < 0.001 | |
| Albumin, < 3.5 g/dL | 31 (8.8) | 13 (54.2) | 18 (5.6) | < 0.001 | |
| Erythrocyte sedimentation rate, > 20 mm/hr | 138 (39.2) | 20 (83.3) | 117 (36.1) | < 0.001 | |
| C-reactive protein, > 0.5 mg/dL | 161 (45.7) | 24 (100) | 135 (41.7) | < 0.001 | |
| Treatments | |||||
| Lopinavir/ritonavir | 190 (54.0) | 21 (87.5) | 167 (51.5) | < 0.001 | |
| Chloroquine | 57 (16.2) | 4 (16.7) | 53 (16.4) | 0.888 | |
| Antibiotics | 149 (42.3) | 22 (91.7) | 126 (38.9) | < 0.001 | |
| Macrolide | 88 (25.0) | 10 (41.7) | 78 (24.1) | 0.036 | |
| Pegylated interferon-α | 57 (16.2) | 12 (50.0) | 45 (13.9) | < 0.001 | |
| O2 supplement | 62 (17.6) | 21 (87.5) | 41 (12.7) | < 0.001 | |
Results are presented as numbers (%).
NA = non-applicable.